Arctigenin Effectively Ameliorates Memory Impairment in Alzheimer's Disease Model Mice Targeting Both β-Amyloid Production and Clearance

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Neuroscience

• Publication date

  2013-08-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1523/JNEUROSCI.4790-12.2013PMID 23926267PMCID PMC6619735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chloroquine in cancer therapy: a double-edged sword of autophagy.

  2013cited by this paper
• Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism.

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor.

  2012cited by this paper
• Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice

  2012cited by this paper
• Endoplasmic Reticulum Stress Induces Tau Pathology and Forms a Vicious Cycle: Implication in Alzheimer's Disease Pathogenesis

  2012cited by this paper
• Astrocyte Senescence as a Component of Alzheimer’s Disease

  2012cited by this paper
• Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway.

  2012cited by this paper
• Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease.

  2012cited by this paper
• AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

  2011cited by this paper
• Progress and prospects: stem cells and neurological diseases

  2011cited by this paper
• Arctigenin Efficiently Enhanced Sedentary Mice Treadmill Endurance

  2011cited by this paper
• Naturally Secreted Amyloid-β Increases Mammalian Target of Rapamycin (mTOR) Activity via a PRAS40-mediated Mechanism*

  2011cited by this paper
• Folic Acid Plus α-Tocopherol Mitigates Amyloid-β-Induced Neurotoxicity through Modulation of Mitochondrial Complexes Activity

  2011cited by this paper
• Selective dihydropyiridine compounds facilitate the clearance of β-amyloid across the blood-brain barrier.

  2011cited by this paper
• Amyloid Clearance as a Treatment Target Against Alzheimer's Disease

  2011cited by this paper
• Differential regulation of BACE1 expression by oxidative and nitrosative signals

  2011cited by this paper
• Antioxidative and in vitro antiproliferative activity of Arctium lappa root extracts

  2011cited by this paper
• Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor

  2011cited by this paper
• Sphingosylphosphorylcholine Attenuated β–Amyloid Production by Reducing BACE1 Expression and Catalysis in PC12 Cells

  2011cited by this paper
• Amyloid-β42 Activates the Expression of BACE1 Through the JNK Pathway

  2011cited by this paper
• A small‐molecule enhancer of autophagy decreases levels of Aβ and APP‐CTF via Atg5‐dependent autophagy pathway

  2011cited by this paper
• PPARγ Co-Activator-1α (PGC-1α) Reduces Amyloid-β Generation Through a PPARγ-Dependent Mechanism

  2011cited by this paper
• Demonstration of safety in Alzheimer's patients for intervention with an anti‐hypertensive drug Nilvadipine: results from a 6‐week open label study

  2011cited by this paper
• Genes Involved in Cerebrospinal Fluid Production as Candidate Genes for Late-Onset Alzheimer's Disease: A Hypothesis

  2011cited by this paper
• Therapeutic effects of remediating autophagy failure in a mouse model of Alzheimer disease by enhancing lysosomal proteolysis

  2011cited by this paper
• Novel synthetic small‐molecule activators of AMPK as enhancers of autophagy and amyloid‐β peptide degradation

  2011cited by this paper
• Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity

  2010cited by this paper
• Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1

  2010cited by this paper
• 2,2′,4′‐Trihydroxychalcone from Glycyrrhiza glabra as a new specific BACE1 inhibitor efficiently ameliorates memory impairment in mice

  2010influential reference
• Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions

  2010influential reference
• Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease

  2010cited by this paper
• Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice

  2010influential reference
• Akt-dependent and -independent mechanisms of mTOR regulation in cancer.

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation.

  2009cited by this paper
• Autophagy for the avoidance of neurodegeneration.

  2009cited by this paper
• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

  2009cited by this paper
• Autophagy fights disease through cellular self-digestion

  2008cited by this paper
• ApoE promotes the proteolytic degradation of Abeta.

  2008cited by this paper
• Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

  2008cited by this paper
• A scientific approach to anti-ageing therapies: state of the art.

  2008cited by this paper
• AMPK phosphorylation of raptor mediates a metabolic checkpoint.

  2008cited by this paper
• AMPK and Raptor: matching cell growth to energy supply.

  2008cited by this paper
• Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila

  2008cited by this paper
• Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.

  2008cited by this paper
• Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

  2008cited by this paper
• BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice.

  2007cited by this paper
• β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Levels Become Elevated in Neurons around Amyloid Plaques: Implications for Alzheimer's Disease Pathogenesis

  2007cited by this paper
• Impaired spatial learning in the APPSwe + PSEN1ΔE9 bigenic mouse model of Alzheimer’s disease

  2007cited by this paper
• Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.

  2007cited by this paper
• siRNA Screening of the Kinome Identifies ULK1 as a Multidomain Modulator of Autophagy*

  2007cited by this paper
• Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

  2006cited by this paper
• Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology

  2005cited by this paper
• p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death

  2005cited by this paper
• Assessment of Spatial Memory Using the Radial Arm Maze and Morris Water Maze

  2004cited by this paper
• The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans.

  2004cited by this paper
• A possible linkage between AMP‐activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway

  2003cited by this paper
• Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Arctigenin protects cultured cortical neurons from glutamate‐induced neurodegeneration by binding to kainate receptor

  2002cited by this paper
• Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease.

  2002cited by this paper
• Phosphorylation of eukaryotic initiation factor-2&agr; (eIF2&agr;) is associated with neuronal degeneration in Alzheimer's disease

  2002cited by this paper
• Platelet‐activating factor acetylhydrolase activity in cerebrospinal fluid of children with acute systemic or neurological illness

  2002cited by this paper
• PKB/AKT: functional insights from genetic models

  2001influential reference
• Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

  2000cited by this paper
• Autophagy as a regulated pathway of cellular degradation.

  2000cited by this paper
• Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase

  1999cited by this paper
• Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation.

  1999cited by this paper
• β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

  1992cited by this paper
• Beta-amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease.

  1992cited by this paper

• Bridging pathway dysfunction and therapy: novel compounds for neuroprotection

  2026cites this paper
• ARC-18 Alleviates Alzheimer-like Pathology and Cognitive Deficits via AdipoR1-Mediated Activation of Autophagy and Modulation of APP Processing

  2026cites this paper
• Modulating Neuroinflammation as a Prospective Therapeutic Target in Alzheimer’s Disease

  2025cites this paper
• Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease.

  2025cites this paper
• Effects of Bioactive Compounds on Autophagy: A Systematic Review

  2025cites this paper
• Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

  2025cites this paper
• Natural Bioactive Compounds as Modulators of Autophagy: A Herbal Approach to the Management of Neurodegenerative Diseases.

  2025cites this paper
• Correction to "Unlocking the Therapeutic Potential of Natural Products for Alzheimer's Disease".

  2025cites this paper
• Investigation of protective effects of olanzapine on impaired learning and memory using behavioral tests in a rat model of Alzheimer’s disease

  2025cites this paper
• Unlocking the Therapeutic Potential of Natural Products for Alzheimer's Disease.

  2025cites this paper
• Natural autophagy modulators in non-communicable diseases: from autophagy mechanisms to therapeutic potential

  2024cites this paper
• Therapeutic Expedition of Luteolin against Brain-related Disorders: An Updated Review.

  2024cites this paper
• Arctigenin from Fructus arctii Exhibits Antiaging Effects via Autophagy Induction, Antioxidative Stress, and Increase in Telomerase Activity in Yeast

  2024influential citation
• Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review

  2024cites this paper
• Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action.

  2024cites this paper
• Pathology reduction and motor behavior improvement associated with ultrasound-mediated delivery of arctiin to the motor cortex in a mutant SOD1 mouse model of amyotrophic lateral sclerosis.

  2024cites this paper
• Arctigenin derivative A‐1 ameliorates motor dysfunction and pathological manifestations in SOD1G93A transgenic mice via the AMPK/SIRT1/PGC‐1α and AMPK/SIRT1/IL‐1β/NF‐κB pathways

  2024cites this paper
• Фитокомплекс специализированного назначения: ингредиентный состав, технология, показатели качества, эффективность

  2023cites this paper
• Therapeutic potential of thymoquinone and its nanoformulations in neuropsychological disorders: a comprehensive review on molecular mechanisms in preclinical studies

  2023cites this paper
• Discovery of a Small-Molecule Modulator of the Autophagy-Lysosome Pathway That Targets Lamin A/C and LAMP1, Induces Autophagic Flux, and Affects Lysosome Positioning in Neurons

  2023cites this paper
• Arctigenin attenuated spatial memory impairment in pR5 mice by regulating mitochondrial energy metabolism.

  2023cites this paper
• Programmed Death of Microglia in Alzheimer’s Disease: Autophagy, Ferroptosis, and Pyroptosis

  2023cites this paper
• The therapeutic potential of arctigenin against multiple human diseases: A mechanistic review.

  2023cites this paper
• A systematic review on botany, ethnopharmacology, quality control, phytochemistry, pharmacology and toxicity of Arctium lappa L. fruit.

  2023cites this paper
• GADD34 suppresses eIF2α phosphorylation and improves cognitive function in Alzheimer's disease-model mice.

  2023cites this paper
• Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease.

  2023cites this paper
• An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease.

  2023cites this paper
• Arctigenin improves neuropathy via ameliorating apoptosis and modulating autophagy in streptozotocin‐induced diabetic mice

  2023cites this paper
• Effect of arctigenin on neurological diseases: A review.

  2023cites this paper
• A monocarboxylate transporter rescues frontotemporal dementia and Alzheimer’s disease models

  2023cites this paper
• Exploring the Mechanism of Arctium Lappa L. Leaves in the Treatment of Alzheimer's Disease Based on Chemical Profile, Network Pharmacology and Molecular Docking

  2023cites this paper
• Evaluation of flaxseed lignan-enriched extract targeting autophagy, apoptosis, and hedgehog pathways against experimentally induced obesity

  2023cites this paper
• Autophagy characteristics of phytoestrogens in management and prevention of diseases: A narrative review of in-vivo and in-vitro studies

  2023cites this paper
• Polyphenols, Autophagy and Neurodegenerative Diseases: A Review

  2023cites this paper
• Lignans as multi‐targeted natural products in neurodegenerative diseases and depression: Recent perspectives

  2023cites this paper
• Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis

  2023cites this paper
• Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer’s Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention

  2023cites this paper
• Arctigenin: A Potential Component with Multifaceted Therapeutic Properties

  2022cites this paper
• Effect of the plant flavonoid, rhoifolin, on memory and cognition in a rat model of Alzheimer’s disease

  2022cites this paper
• Notopterygium incisum Root Extract (NRE) Alleviates Epileptiform Symptoms in PTZ-Induced Acute Seizure Mice.

  2022cites this paper
• Arctigenin attenuates paraquat-induced human lung epithelial A549 cell injury by suppressing ROS/p38 mitogen-activated protein kinases-mediated apoptosis.

  2022cites this paper
• Arctigenin: pharmacology, total synthesis, and progress in structure modification

  2022cites this paper
• The role of the mTOR pathway in diabetic retinopathy

  2022cites this paper
• Serial five-membered lactone ring ions in the treatment of Alzheimer’s diseases-comprehensive profiling of arctigenin metabolites and network analysis

  2022cites this paper
• Synthesis and evaluation of multi-target-directed ligands with BACE-1 inhibitory and Nrf2 agonist activities as potential agents against Alzheimer's disease.

  2021cites this paper
• Natural products as geroprotectors: An autophagy perspective

  2021cites this paper
• Fructus arctii: an overview on its traditional uses, pharmacology and phytochemistry.

  2021cites this paper
• Alzheimer's Disease and Protein Kinases.

  2021cites this paper
• Piper sarmentosum Roxb. Attenuates Beta Amyloid (Aβ)-Induced Neurotoxicity Via the Inhibition of Amyloidogenesis and Tau Hyperphosphorylation in SH-SY5Y Cells.

  2021cites this paper
• Bulbocodin D ameliorate cognitive impairment in APP/PS1 transgenic mice by modulating amyloid-beta burden, oxidative status and neuroinflammation

  2021cites this paper
• Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents

  2021cites this paper
• Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy

  2021cites this paper
• Highlighting the protective or degenerative role of AMPK activators in dementia experimental models.

  2021cites this paper
• Adiponectin: a potential target for obesity-associated Alzheimer’s disease

  2021cites this paper
• Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer’s disease

  2021cites this paper
• The PI3K/Akt signaling axis in Alzheimer’s disease: a valuable target to stimulate or suppress?

  2021cites this paper
• The neuroprotective effects of polyphenols, their role in innate immunity and the interplay with the microbiota.

  2021cites this paper
• Pharmacological modulation of autophagy for Alzheimer's disease therapy: Opportunities and obstacles

  2021cites this paper
• Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease – a patent review (2016–present)

  2021cites this paper
• Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress

  2020cites this paper
• Dysfunctional Autophagy and Endolysosomal System in Neurodegenerative Diseases: Relevance and Therapeutic Options

  2020cites this paper
• Arctigenin Suppressed Epithelial-Mesenchymal Transition Through Wnt3a/β-Catenin Pathway in PQ-Induced Pulmonary Fibrosis

  2020cites this paper
• The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention

  2020cites this paper
• The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice

  2020cites this paper
• Arctigenin suppresses cell proliferation via autophagy inhibition in hepatocellular carcinoma cells

  2020cites this paper
• Molecular Mechanisms of ER Stress and UPR in the Pathogenesis of Alzheimer’s Disease

  2020cites this paper
• Trehalose Inhibits Aβ Generation and Plaque Formation in Alzheimer’s Disease

  2020cites this paper
• A natural BACE1 and GSK3β dual inhibitor Notopterol effectively ameliorates the cognitive deficits in APP/PS1 Alzheimer's mice by attenuating amyloid-β and tau pathology.

  2020cites this paper
• DW14006 as a direct AMPKα1 activator improves pathology of AD model mice by regulating microglial phagocytosis and neuroinflammation.

  2020cites this paper
• Molecular diagnosis and drug development in both Alzheimer's and Parkinson's diseases

  2020cites this paper
• Echinacoside Suppresses Amyloidogenesis and Modulates F-actin Remodeling by Targeting the ER Stress Sensor PERK in a Mouse Model of Alzheimer’s Disease

  2020influential citation
• Molecular Insights into the Multifunctional Role of Natural Compounds: Autophagy Modulation and Cancer Prevention

  2020cites this paper
• A mechanistic insight of phytoestrogens used for Rheumatoid arthritis: An evidence-based review.

  2020cites this paper
• Plant natural products for cognitive impairment: A review of the preclinical evidence

  2020cites this paper
• Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes

  2019cites this paper
• Receptor-Interacting Protein Kinase 1 (RIPK1) as a Potential Therapeutic Target: An Overview of Its Possible Role in the Pathogenesis of Alzheimer's Disease.

  2019cites this paper
• Protective Role of Apigenin Against Aβ 25–35 Toxicity Via Inhibition of Mitochondrial Cytochrome c Release

  2019cites this paper
• Autophagy in Human Health and Disease: Novel Therapeutic Opportunities

  2019cites this paper
• Phytoconstituents and their Possible Mechanistic Profile for Alzheimer's Disease - A Literature Review.

  2019cites this paper
• Royal Jelly Alleviates Cognitive Deficits and β-Amyloid Accumulation in APP/PS1 Mouse Model Via Activation of the cAMP/PKA/CREB/BDNF Pathway and Inhibition of Neuronal Apoptosis

  2019cites this paper
• Glaucocalyxin A as a natural product increases amyloid &bgr; clearance and decreases tau phosphorylation involving the mammalian target of rapamycin signaling pathway

  2019cites this paper
• Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine

  2019cites this paper
• Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice

  2019cites this paper
• Effect of Both Phytoestrogen and Xenoestrogen on Some Sexual Hormones in Male Albino Rats and Illustration of The Effect of Arctium Lappa L (A. Lappa) on Their Actions

  2019cites this paper
• Notopterygium incisum extract (NRE) rescues cognitive deficits in APP/PS1 Alzhneimer's disease mice by attenuating amyloid-beta, tau, and neuroinflammation pathology.

  2019cites this paper
• ERα Gene Promoter Methylation in Cognitive Function and Quality of Life of Patients With Alzheimer Disease

  2019cites this paper
• Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice

  2019cites this paper
• Amentoflavone suppresses Amyloid β1-42 neurotoxicity in Alzheimer's disease through the inhibition of pyroptosis.

  2019cites this paper
• Recent progress in the role of autophagy in neurological diseases

  2019cites this paper
• Age- and Nicotine-Associated Gene Expression Changes in the Hippocampus of APP/PS1 Mice

  2019cites this paper
• 3′‐Desmethylarctigenin induces G2/M cell cycle arrest and apoptosis through reactive oxygen species generation in hepatocarcinoma cells

  2019cites this paper
• Euxanthone Attenuates Aβ1–42-Induced Oxidative Stress and Apoptosis by Triggering Autophagy

  2018cites this paper
• Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis

  2018cites this paper
• Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice.

  2018influential citation
• The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.

  2018cites this paper
• Two pairs of new alkaloid enantiomers with a spiro [benzofuranone-benzazepine] skeleton from the bark of Juglans mandshurica

  2018cites this paper
• Novel Pathways of Autophagy for the Treatment of Nervous System Disorders

  2018cites this paper
• Neuroprotective effect of arctigenin against neuroinflammation and oxidative stress induced by rotenone

  2018cites this paper
• Autophagy in neurodegenerative diseases: pathogenesis and therapy

  2018cites this paper
• Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer’s Disease

  2018cites this paper